ArticleJournal of ginseng research2026
Efficacy of Panax notoginseng saponins on functional outcome in obese patients with acute ischemic stroke.
Article in Journal of ginseng research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity exacerbates acute ischemic stroke (AIS) outcomes through metabolic dysfunction and chronic inflammation. Although Methods: This analysis utilized individual patient data from the PANDA trial. Participants were stratified by body mass index (BMI), waist circumference (WC), and a combination of both metrics. The primary outcome was functional independence, defined as a modified Rankin Scale (mRS) score of 0-2 at 90 days. Adjusted odds ratios (aORs) were calculated using multivariable logistic regression. Results: Among 2,779 patients (mean age 60.7 ± 9.3 years), 58.3% were classified as overweight or obese by BMI, and 65% met criteria for abdominal obesity based on WC. PNS significantly improved rates of functional independence at 90 days across overweight (aOR = 2.05; 95% CI: 1.39-3.06), obesity (aOR = 2.18; 95% CI: 1.11-4.41), and abdominal obesity (aOR = 2.37; 95% CI: 1.73-3.28) subgroups. Consistent benefits were observed in patients with abdominal obesity irrespective of BMI category: lower BMI (aOR = 2.45; 95% CI: 1.34-4.61) and higher BMI (aOR = 2.40; 95% CI: 1.64-3.54). Conclusions: These results indicate that PNS may improve 90-day functional outcomes in patients with AIS and obesity, including those with abdominal obesity, warranting further prospective validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.